Axsome Therapeutics AXSM
NASDAQ AXSM
$149.24 +8.27 (+5.87%)
At close: Nov 11, 2026 · 4:00 PM EST

Axsome Therapeutics (AXSM) Cash & Current Investments (2014 - 2026)

Updated

Axsome Therapeutics' Cash & Current Investments was $313.86 million in Q3 2026, down 3.5% from $325.27 million a year earlier and down 1.9% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Cash & Current Investments (2014 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Axsome Therapeutics came in at $322.93 million, up 2.4% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $315.35 million in FY2024 (-18.3%), $386.19 million in FY2023 (+92.3%), $200.84 million in FY2022 (+132.3%) and $86.47 million in FY2021 (-53.0%).
  • Quarterly Cash & Current Investments has moved between $73.39 million (Q2 2022) and $437.11 million (Q2 2023) over five years.
  • Compared with a year earlier, Cash & Current Investments was higher in three of the last eight quarters, with an average decline of 3.3%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q2 2023 (growth of 495.6%); the worst was Q4 2021 (a decline of 53.0%).
  • Per Business Quant data, AXSM's Cash & Current Investments in the three quarters before Q3 2026 was $319.85 million (Q2 2026), $305.11 million (Q1 2026) and $322.93 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Axsome Therapeutics 7.41 Bn 6.15 Bn 241.89 Mn 313.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 313.86 Mn
Jun 30, 2026 319.85 Mn
Mar 31, 2026 305.11 Mn
Dec 31, 2025 322.93 Mn
Sep 30, 2025 325.27 Mn
Jun 30, 2025 303.02 Mn
Mar 31, 2025 300.91 Mn
Dec 31, 2024 315.35 Mn
Sep 30, 2024 327.34 Mn
Jun 30, 2024 315.66 Mn
Mar 31, 2024 331.44 Mn
Dec 31, 2023 386.19 Mn
Sep 30, 2023 416.56 Mn
Jun 30, 2023 437.11 Mn
Mar 31, 2023 246.52 Mn
Dec 31, 2022 200.84 Mn
Sep 30, 2022 227.52 Mn
Jun 30, 2022 73.39 Mn
Mar 31, 2022 84.71 Mn
Dec 31, 2021 86.47 Mn
API Access

Axsome Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AXSM&period=max&api_key=YOUR_API_KEY